Physician profile
Thomas D Ade
NPI 1568448884
$11,865.70
in general payments reported to CMS, 2019-2025
62 companies · $2,832 in 2025
The $2,832 reported for 2025 was more than what 82% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $251 · 2020: $735 · 2021: $1,859 · 2022: $1,500 · 2023: $2,372 · 2024: $2,317 · 2025: $2,832.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,237 · Education: $284.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,237.12 |
| Education | $283.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $2,001.24 | 2019-2025 | Farxiga, Fasenra, Tezspire |
| Boehringer Ingelheim Pharmaceuticals, INC. | $901.54 | 2019-2025 | Jardiance, Ofev, Spiriva Respimat |
| Abbvie INC. | $684.57 | 2021-2025 | Vraylar, Qulipta, Ubrelvy |
| Amgen INC. | $615.35 | 2019-2025 | Evenity, Prolia, Tezspire |
| Glaxosmithkline, LLC. | $594.23 | 2020-2025 | Trelegy Ellipta, Nucala, Shingrix |
| Pfizer INC. | $574.42 | 2019-2025 | |
| Novo Nordisk INC | $527.17 | 2020-2025 | Ozempic, Rybelsus, Wegovy |
| Ironwood Pharmaceuticals, INC | $442.37 | 2021-2024 | Linzess |
| Astellas Pharma US INC | $366.96 | 2020-2024 | Veozah |
| Lilly USA, LLC | $349.29 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Regeneron Healthcare Solutions, INC. | $268.98 | 2022-2024 | Dupixent |
| Novartis Pharmaceuticals Corporation | $265.69 | 2022-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $263.62 | 2021-2025 | |
| Amarin Pharma, INC. | $241.81 | 2020-2022 | |
| Teva Pharmaceuticals USA, INC. | $238.23 | 2019-2025 | Austedo Xr, Austedo Xr, Austedo |
Show all 62 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $234.74 | 2020-2025 | Camzyos, Eliquis |
| Exact Sciences Corporation | $206.85 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Allergan, INC. | $195.38 | 2019-2020 | |
| Grifols USA, LLC | $185.94 | 2024-2025 | Prolastin-C Liquid |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $180.56 | 2021-2025 | Xifaxan, Trulance |
| Harmony Biosciences LLC | $175.82 | 2020-2025 | Wakix |
| Aimmune Therapeutics, INC. | $174.32 | 2024-2025 | Zenpep |
| Janssen Pharmaceuticals, INC | $164.85 | 2019-2024 | Xarelto |
| Baxter Healthcare | $160.23 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Cardiac Ambulatory Monitor, Hillrom - Monarch Airway Clearance System |
| Nestle Healthcare Nutrition INC. | $141.64 | 2020-2023 | |
| Kowa Pharmaceuticals America, INC. | $138.88 | 2021-2025 | Zoryve, Seglentis |
| Genzyme Corporation | $108.94 | 2023-2025 | |
| Dexcom, INC. | $97.51 | 2021-2024 | Dexcom G6 Transmitter |
| Verona Pharma, INC. | $96.40 | 2025 | Ohtuvayre |
| Eisai INC. | $91.82 | 2020-2025 | |
| Mylan Specialty L.P. | $83.21 | 2019-2024 | Yupelri |
| Almatica Pharma LLC | $83.00 | 2022-2023 | Loreev Xr, Gralise |
| United Therapeutics Corporation | $82.11 | 2021-2022 | |
| Lundbeck LLC | $78.67 | 2023-2025 | Rexulti |
| Intuitive Surgical, INC. | $76.23 | 2024 | |
| Merck Sharp & Dohme LLC | $74.03 | 2021-2025 | Verquvo, Steglatro, Belsomra |
| Takeda Pharmaceuticals U.S.A., INC. | $64.43 | 2021-2025 | Cuvitru, Glassia |
| Abbott Laboratories | $58.90 | 2021-2025 | Freestyle Libre 3 |
| Sanofi-Aventis U.S. LLC | $48.10 | 2020-2021 | |
| Insmed, INC. | $44.73 | 2024-2025 | Arikayce |
| Phathom Pharmaceuticals, INC. | $38.80 | 2024 | Voquezna |
| Otsuka America Pharmaceutical, INC. | $37.00 | 2023-2025 | Rexulti |
| Radius Health, INC. | $34.96 | 2025 | Tymlos |
| Vertex Pharmaceuticals Incorporated | $32.68 | 2025 | |
| Actelion Pharmaceuticals US, INC. | $32.45 | 2022-2023 | Opsumit, Uptravi |
| Daiichi Sankyo INC. | $30.32 | 2020-2021 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $26.51 | 2022 | |
| Mallinckrodt Hospital Products INC. | $22.54 | 2025 | Acthar |
| Neurocrine Biosciences, INC. | $22.44 | 2023 | Ingrezza |
| Electromed, INC. | $22.35 | 2023 | Smartvest |
| Ascensia Diabetes Care US INC. | $21.64 | 2025 | |
| Lexicon Pharmaceuticals, INC. | $19.32 | 2024 | |
| Phadia US INC. | $19.04 | 2020 | |
| Xeris Pharmaceuticals, INC. | $18.83 | 2023 | Gvoke Hypopen |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $16.48 | 2025 | Caplyta |
| Jazz Pharmaceuticals INC. | $15.59 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $14.12 | 2021 | |
| Circassia INC. | $13.53 | 2019 | |
| Idorsia Pharmaceuticals US INC | $12.57 | 2022 | |
| Esperion Therapeutics, INC. | $12.23 | 2021 | |
| Axsome Therapeutics, INC. | $12.23 | 2022 | |
| Inogen, INC. | $7.31 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Ade listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.